• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

偏头痛是儿童和青少年中最具致残性的神经疾病,在成年人中仅次于中风:行动呼吁。

Migraine is the most disabling neurological disease among children and adolescents, and second after stroke among adults: A call to action.

机构信息

Institute of Psychiatry, HCFMUSP, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

Department of Neurology, Hospital Albert Einstein, São Paulo, Brazil.

出版信息

Cephalalgia. 2024 Aug;44(8):3331024241267309. doi: 10.1177/03331024241267309.

DOI:10.1177/03331024241267309
PMID:39197864
Abstract

The Global Burden of Disease (GBD) study is pivotal in shaping health policies by providing comprehensive data on mortality and disability. An updated GBD2021 analysis, published in on 14 March 2024, expands the scope of neurological disorders to include 37 conditions, revealing their significant impact on global health. Neurological disorders affect 3.4 billion people, or 43.1% of the global population, making them the leading cause of disability-adjusted life years (DALYs) in 2021, with an 18.2% increase since 1990. The top three causes of DALYs in this category are stroke, neonatal encephalopathy and migraine. Migraine, affecting 1.16 billion people, ranks first among children and adolescents and second among adults aged under 60 years. Despite its substantial impact, migraine often lacks proper attention because of its non-fatal nature, invisibility and historical neglect of neurological disorders. The International Headache Society calls for recognizing migraine as a serious medical condition, promoting research and integrating migraine management into public health strategies. Effective interventions include raising awareness, improving access to treatment, adding migraine to the epidemiological surveillance agenda and exploring new treatment strategies. A coordinated effort among stakeholders is essential to alleviate the burden of migraine on individuals and society.

摘要

全球疾病负担(GBD)研究通过提供死亡率和残疾数据,在制定卫生政策方面发挥着关键作用。2024 年 3 月 14 日发表在[期刊名称]上的 GBD2021 更新分析扩展了神经系统疾病的范围,纳入了 37 种疾病,揭示了它们对全球健康的重大影响。神经系统疾病影响了 34 亿人,占全球人口的 43.1%,是 2021 年伤残调整生命年(DALY)的主要原因,自 1990 年以来增加了 18.2%。该类别中 DALY 的前三个原因是中风、新生儿脑病和偏头痛。偏头痛影响了 11.6 亿人,在儿童和青少年中排名第一,在 60 岁以下成年人中排名第二。尽管偏头痛的影响很大,但由于其非致命性、不可见性和历史上对神经系统疾病的忽视,往往得不到适当的关注。国际头痛学会呼吁将偏头痛视为一种严重的医疗状况,促进研究并将偏头痛管理纳入公共卫生战略。有效的干预措施包括提高认识、改善治疗机会、将偏头痛纳入流行病学监测议程以及探索新的治疗策略。利益相关者之间的协调努力对于减轻偏头痛对个人和社会的负担至关重要。

相似文献

1
Migraine is the most disabling neurological disease among children and adolescents, and second after stroke among adults: A call to action.偏头痛是儿童和青少年中最具致残性的神经疾病,在成年人中仅次于中风:行动呼吁。
Cephalalgia. 2024 Aug;44(8):3331024241267309. doi: 10.1177/03331024241267309.
2
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病、伤害和危险因素负担研究 2021 年,1990-2021 年全球 204 个国家和地区及 811 个次国家地区 371 种疾病和伤害的发病率、患病率、伤残损失生命年(YLDs)、伤残调整生命年(DALYs)以及健康期望寿命(HALE):系统分析
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.
3
Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家偏头痛和紧张型头痛负担,1990-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2018 Nov;17(11):954-976. doi: 10.1016/S1474-4422(18)30322-3.
4
Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家神经障碍负担,1990-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2019 May;18(5):459-480. doi: 10.1016/S1474-4422(18)30499-X. Epub 2019 Mar 14.
5
Global, regional, and national epidemiology of migraine and tension-type headache in youths and young adults aged 15-39 years from 1990 to 2019: findings from the global burden of disease study 2019.全球、区域和国家 1990 年至 2019 年 15-39 岁青少年和青年偏头痛和紧张型头痛的流行病学:2019 年全球疾病负担研究的结果。
J Headache Pain. 2023 Sep 18;24(1):126. doi: 10.1186/s10194-023-01659-1.
6
The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017.欧洲神经疾病负担:2017 年全球疾病负担研究分析。
Lancet Public Health. 2020 Oct;5(10):e551-e567. doi: 10.1016/S2468-2667(20)30190-0.
7
Global, regional, and national burden and trends of migraine among youths and young adults aged 15-39 years from 1990 to 2021: findings from the global burden of disease study 2021.全球、区域和国家 1990 年至 2021 年 15-39 岁青少年和青年人群偏头痛负担和趋势:来自 2021 年全球疾病负担研究的结果。
J Headache Pain. 2024 Aug 12;25(1):131. doi: 10.1186/s10194-024-01832-0.
8
Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.1990 - 2015年全球、区域和国家神经系统疾病负担:全球疾病负担研究2015的系统分析
Lancet Neurol. 2017 Nov;16(11):877-897. doi: 10.1016/S1474-4422(17)30299-5. Epub 2017 Sep 17.
9
Global Burden of Headache Disorders in Children and Adolescents 2007-2017.全球儿童和青少年头痛障碍负担:2007-2017 年。
Int J Environ Res Public Health. 2020 Dec 31;18(1):250. doi: 10.3390/ijerph18010250.
10
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.

引用本文的文献

1
Global, regional, and national burden and trends of headache disorders among children and adolescent (5-24 years old) from 1990 to 2021.1990年至2021年全球、区域和国家5至24岁儿童及青少年头痛疾病的负担和趋势
BMC Neurol. 2025 Aug 27;25(1):357. doi: 10.1186/s12883-025-04367-2.
2
Global, regional, and national epidemiology of neurological disorders and subcategories: incidence and disability-adjusted life years, 1990-2021.全球、区域和国家神经系统疾病及其亚类的流行病学:1990 - 2021年发病率及伤残调整生命年
Eur J Med Res. 2025 Aug 5;30(1):711. doi: 10.1186/s40001-025-02958-w.
3
Developmental trends in headache: an Italian school-based study of age- and gender-related changes in clinical characteristics and burden from childhood to adolescence.
头痛的发育趋势:一项基于意大利学校的研究,探讨从童年到青春期临床特征和负担方面与年龄及性别相关的变化。
Ther Adv Neurol Disord. 2025 Jul 18;18:17562864251356066. doi: 10.1177/17562864251356066. eCollection 2025.
4
Dissecting Causal Relationships Between Gut Microbiota, Immunocyte Phenotype, and Migraine: A Mendelian Randomization Study.剖析肠道微生物群、免疫细胞表型与偏头痛之间的因果关系:一项孟德尔随机化研究。
Brain Behav. 2025 Jul;15(7):e70693. doi: 10.1002/brb3.70693.
5
Global, regional, and national burdens and trends of migraine among males aged 10-59 years from 1990 to 2021: insights from the Global Burden of Disease study 2021.1990年至2021年10至59岁男性偏头痛的全球、区域和国家负担及趋势:来自《2021年全球疾病负担研究》的见解
Front Neurol. 2025 Jun 6;16:1585512. doi: 10.3389/fneur.2025.1585512. eCollection 2025.
6
The Second Exteroceptive Suppression Period of the Temporalis Muscle Is Altered in Migraine Patients with Allodynia.偏头痛伴痛觉过敏患者颞肌的第二外感受性抑制期发生改变。
Neurol Int. 2025 May 16;17(5):76. doi: 10.3390/neurolint17050076.
7
Analysis of headache burden Chinese in the global context from 1990 to 2021.1990年至2021年全球背景下中国头痛负担分析。
Front Neurol. 2025 Apr 16;16:1559028. doi: 10.3389/fneur.2025.1559028. eCollection 2025.
8
Acupuncture Versus Standard Medical Care in the Prophylactic Treatment of Migraine: A Systematic Review and Meta-Analysis.针刺疗法与标准医疗护理用于偏头痛预防性治疗的系统评价与Meta分析
Eur J Neurol. 2025 Apr;32(4):e70160. doi: 10.1111/ene.70160.
9
The serum proteomic profile in patients with migraine.偏头痛患者的血清蛋白质组图谱。
Front Mol Neurosci. 2025 Mar 24;18:1460403. doi: 10.3389/fnmol.2025.1460403. eCollection 2025.
10
Efficacy and continuability of 675 mg fremanezumab administration over 2 years.675毫克孚来美单抗给药2年的疗效及持续性
J Headache Pain. 2025 Mar 11;26(1):51. doi: 10.1186/s10194-025-01994-5.